Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development

Ann Rheum Dis. 2023 May;82(5):724-726. doi: 10.1136/ard-2022-223417. Epub 2023 Jan 5.
No abstract available

Keywords: Anti-Citrullinated Protein Antibodies; Arthritis, Experimental; Arthritis, Rheumatoid; Autoimmunity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents
  • Arthritis* / drug therapy
  • Autoantibodies
  • Humans
  • Peptides, Cyclic
  • Rheumatoid Factor*

Substances

  • Rheumatoid Factor
  • Anti-Inflammatory Agents
  • Autoantibodies
  • Peptides, Cyclic